BioScrip to sell 6.8M shares in public offering
ELMSFORD, N.Y. – BioScrip, a provider of infusion and homecare services, has upped the ante on its public offering. The company announced Aug. 14 that it will offer 6,895,873 shares instead of 6,800,000, all of which are being sold by existing stockholders. The underwriter of the offering, Morgan Stanley, has 30 days to purchase up to an additional 1,020,000 shares from selling stockholders. BioScrip will not receive any of the proceeds from the initial sale of the shares. The offering is expected to close Aug. 19.